Cargando…

Neuroprotective Effect and Possible Mechanisms of Berberine in Diabetes-Related Cognitive Impairment: A Systematic Review and Meta-Analysis of Animal Studies

Berberine, the main bioactive component of Coptis chinensis Franch., is widely used in the treatment of diabetes. Previous studies have reported that berberine supplementation may play a multitarget therapeutic role in diabetes-related cognitive impairment (DCI). This systematic review and meta-anal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hao, Yanwei, Li, Jiaxin, Yue, Shengnan, Wang, Shaofeng, Hu, Shuangyuan, Li, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208278/ https://www.ncbi.nlm.nih.gov/pubmed/35734409 http://dx.doi.org/10.3389/fphar.2022.917375

Ejemplares similares

Pharmacological effects of berberine on models of ulcerative colitis: A meta-analysis and systematic review of animal studies
por: Hu, Shuangyuan, et al.
Publicado: (2022)

Promising Antioxidative Effect of Berberine in Cardiovascular Diseases
por: An, Na, et al.
Publicado: (2022)

Effects of Berberine on Atherosclerosis
por: Rui, Rui, et al.
Publicado: (2021)

Preclinical Evidence of Berberine on Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Animal Studies
por: Ren, Sichen, et al.
Publicado: (2021)

Dengzhanxixin Injection Ameliorates Cognitive Impairment Through a Neuroprotective Mechanism Based on Mitochondrial Preservation in Patients With Acute Ischemic Stroke
por: An, Haiting, et al.
Publicado: (2021)

Berberine Maintains the Neutrophil N1 Phenotype to Reverse Cancer Cell Resistance to Doxorubicin
por: Zhang, Shuhui, et al.
Publicado: (2020)

Berberine Improves Irinotecan-Induced Intestinal Mucositis Without Impairing the Anti-colorectal Cancer Efficacy of Irinotecan by Inhibiting Bacterial β-glucuronidase
por: Yue, Bei, et al.
Publicado: (2021)

Effect of Berberine on Atherosclerosis and Gut Microbiota Modulation and Their Correlation in High-Fat Diet-Fed ApoE−/− Mice
por: Wu, Min, et al.
Publicado: (2020)

Neuroprotective effect of berberine chloride on cognitive impairment and hippocampal damage in experimental model of vascular dementia
por: Aski, Mahila Lotfi, et al.
Publicado: (2018)

Berberine-Loaded Carboxylmethyl Chitosan Nanoparticles Ameliorate DSS-Induced Colitis and Remodel Gut Microbiota in Mice
por: Zhao, Luqing, et al.
Publicado: (2021)

Berberine Ameliorates Spatial Learning Memory Impairment and Modulates Cholinergic Anti-Inflammatory Pathway in Diabetic Rats
por: Wang, Kaifu, et al.
Publicado: (2019)

Protective Effect and Possible Mechanisms of Astragaloside IV in Animal Models of Diabetic Nephropathy: A Preclinical Systematic Review and Meta-Analysis
por: Wang, Hong, et al.
Publicado: (2020)

Cannabinoid Drugs-Related Neuroprotection as a Potential Therapeutic Tool Against Chemotherapy-Induced Cognitive Impairment
por: Boullon, Laura, et al.
Publicado: (2021)

Ligustrazine Exerts Cardioprotection in Animal Models of Myocardial Ischemia/Reperfusion Injury: Preclinical Evidence and Possible Mechanisms
por: Zheng, Qun, et al.
Publicado: (2018)

Berberine: A Promising Treatment for Neurodegenerative Diseases
por: Cheng, Ziqian, et al.
Publicado: (2022)

Neuroprotective effects of berberine in animal models of Alzheimer’s disease: a systematic review of pre-clinical studies
por: Yuan, Ning-Ning, et al.
Publicado: (2019)

Brimonidine is Neuroprotective in Animal Paradigm of Retinal Ganglion Cell Damage
por: Conti, Federica, et al.
Publicado: (2021)

A Novel Berberine–Glycyrrhizic Acid Complex Formulation Enhanced the Prevention Effect to Doxorubicin-Induced Cardiotoxicity by Pharmacokinetic Modulation of Berberine in Rats
por: Zhang, Shichang, et al.
Publicado: (2022)

Current Evidence and Future Directions of Berberine Intervention in Depression
por: Zhu, Wen-Qian, et al.
Publicado: (2022)

Advances of berberine against metabolic syndrome-associated kidney disease: Regarding effect and mechanism
por: Liu, Ya-Fei, et al.
Publicado: (2023)

Berberine Protects Against NLRP3 Inflammasome via Ameliorating Autophagic Impairment in MPTP-Induced Parkinson’s Disease Model
por: Huang, Shuxuan, et al.
Publicado: (2021)

Adipose Tissue SIRT1 Regulates Insulin Sensitizing and Anti-Inflammatory Effects of Berberine
por: Shan, Yun, et al.
Publicado: (2020)

Berberine-Incorporated Shape Memory Fiber Applied as a Novel Surgical Suture
por: Zhou, Wen-cheng, et al.
Publicado: (2020)

Neuroprotective Studies on Polygonum hydropiper L. Essential Oils Using Transgenic Animal Models
por: Tong, Xin, et al.
Publicado: (2021)

Fasudil, a Rho-Kinase Inhibitor, Exerts Cardioprotective Function in Animal Models of Myocardial Ischemia/Reperfusion Injury: A Meta-Analysis and Review of Preclinical Evidence and Possible Mechanisms
por: Huang, Yue-yue, et al.
Publicado: (2018)

Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis
por: Xie, Wenting, et al.
Publicado: (2022)

Polypharmacology of Berberine Based on Multi-Target Binding Motifs
por: Chu, Ming, et al.
Publicado: (2018)

Berberine Ameliorates Diabetes-Associated Cognitive Decline through Modulation of Aberrant Inflammation Response and Insulin Signaling Pathway in DM Rats
por: Chen, Qingjie, et al.
Publicado: (2017)

Berberine Facilitates Extinction and Prevents the Return of Fear
por: Huang, Shihao, et al.
Publicado: (2022)

Protective effects and possible mechanisms of catalpol against diabetic nephropathy in animal models: a systematic review and meta-analysis
por: Fu, Zhongmei, et al.
Publicado: (2023)

Neuroprotective Properties of Berberine: Molecular Mechanisms and Clinical Implications
por: Tian, Erjie, et al.
Publicado: (2023)

Berberine Potentiates Insulin Secretion and Prevents β-cell Dysfunction Through the miR-204/SIRT1 Signaling Pathway
por: Lv, Xiaoyan, et al.
Publicado: (2021)

Therapeutic Effects of Berberine on Liver Fibrosis are associated With Lipid Metabolism and Intestinal Flora
por: Liu, Xianzhi, et al.
Publicado: (2022)

Berberine Attenuates Chronic Atrophic Gastritis Induced by MNNG and Its Potential Mechanism
por: Tong, Yuling, et al.
Publicado: (2021)

Efficacy and underlying mechanisms of berberine against lipid metabolic diseases: a review
por: Cai, Yajie, et al.
Publicado: (2023)

Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota
por: Yang, Shengjie, et al.
Publicado: (2021)

The neuroprotective effect of dexmedetomidine and its mechanism
por: Hu, Yijun, et al.
Publicado: (2022)

Combined Use of Bicyclol and Berberine Alleviates Mouse Nonalcoholic Fatty Liver Disease
por: Li, Hu, et al.
Publicado: (2022)

A New Therapeutic Candidate for Cardiovascular Diseases: Berberine
por: Cai, Yun, et al.
Publicado: (2021)

Pharmacokinetics and Excretion of Berberine and Its Nine Metabolites in Rats
por: Feng, Xinchi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_64p1eehlgjmvt2rq56d0f5h3oj